H. Howard

发表

Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines.

B. Dominy, R. Sarges, A. Weissman, 1986, Journal of medicinal chemistry.

Antipsychotic drugs: recent developments and novel agents

H. Howard, 1997 .

Synthesis of 2H-, 3H- and 14C-labelled CP-45,634 (sorbinil)

R. Sarges, H. Howard, M. Evans, 1991 .

7-Phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents

H. Howard, 2005 .

Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.

C. Prakash, H. Howard, A. Kamel, 1997, Drug metabolism and disposition: the biological fate of chemicals.

4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.

R. G. Browne, P. Seymour, R. Sarges, 1990, Journal of medicinal chemistry.

4‐Amino(1,2,4)triazolo(4,3‐a)quinoxalines. A Novel Class of Potent Adenosine Receptor Antagonists and Potential Rapid‐Onset Antidepressants.

R. G. Browne, P. Seymour, R. Sarges, 1991 .

3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.

Anne W. Schmidt, J. Lowe, P. Seymour, 1996, Journal of medicinal chemistry.

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Anne W. Schmidt, J. Lowe, P. Seymour, 1995, The Journal of pharmacology and experimental therapeutics.

Synthesis of optically active spirohydantoins by asymmetric induction. Hydantoin formation from amino nitriles and chlorosulfonyl isocyanates

R. Sarges, H. Howard, P. Kelbaugh, 1982 .

1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents.

Anne W. Schmidt, J. Lowe, P. Seymour, 1991, Journal of medicinal chemistry.

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.

Anne W. Schmidt, S. Zorn, H. Howard, 2001, European journal of pharmacology.

Update Central & Peripheral Nervous Systems Antipsychotic drugs: recent developments and novel agents

H. Howard, 1997 .

A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindoles.

A. Weissman, H. Howard, B. Koe, 1989, Journal of medicinal chemistry.

Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764).

Jiri Aubrecht, Scot Mente, Jennifer B Munzner, 2011, Journal of medicinal chemistry.

Fused thiazole derivatives having affinity for the histamine H3 receptor

H. Howard, 2007 .

4-Arylpiperidine derivatives and uses thereof for preparing a medicament for the treatment of CNS disorders

H. Howard, 2007 .

Agents for attention-deficit hyperactivity disorder – an update

H. Howard, 2004 .

METABOLISM AND EXCRETION OF THE NOVEL ANTIPSYCHOTIC DRUG ZIPRASIDONE IN RATS AFTER ORAL ADMINISTRATION OF A MIXTURE OF 14 C- AND 3 H-LABELED ZIPRASIDONE

C. Prakash, H. Howard, A. Kamel, 1997 .

Chapter 5. Novel Antipsychotics

T. Seeger, H. Howard, 1993 .

Therapeutic agents for attention deficit disorders

H. Howard, 2000 .

Cyclopropyl methanone derivatives, their preparation and their therapeutic use

H. Howard, 2005 .

Synthesis of conformationally restricted substance P antagonists

K. Shenk, S. Mclean, H. Howard, 1995 .